For the quarter ending 2026-03-31, KPHMW has $21,227,089 in assets. $7,292,528 in debts. $10,955,359 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Tax receivables | - | - | - | 696,002 |
| Cash and cash equivalents | 10,955,359 | 8,696,570 | 5,508,899 | 1,028,324 |
| Short-term investments | 2,916,701 | 8,392,513 | 13,866,546 | 19,637,812 |
| Prepaid expenses and other current assets | 1,206,339 | 1,141,804 | 650,429 | 957,095 |
| Collaboration receivables | 1,544,253 | 1,522,770 | 1,213,226 | 2,418,022 |
| Tax and other receivables | 1,906,923 | 1,793,459 | 1,454,756 | - |
| Prepaid collaboration expenses | 153,273 | 201,332 | - | - |
| Total current assets | 18,682,848 | 21,748,448 | 22,693,856 | 24,737,255 |
| Property and equipment, net | 86,815 | 91,672 | 101,807 | 106,843 |
| Restricted cash | 4,687 | 4,566 | 4,520 | 4,461 |
| Intangible assets and in-process r&d, net | 2,063,100 | 2,063,100 | 6,687,100 | 6,687,100 |
| Operating lease right-of-use assets | 301,486 | 285,827 | 318,036 | 349,017 |
| Other assets | 88,153 | 59,687 | 58,135 | 61,007 |
| Total assets | 21,227,089 | 24,253,300 | 29,863,454 | 31,945,683 |
| Accounts payable | 594,874 | 1,060,306 | 241,471 | 282,537 |
| Accrued collaboration credit | - | 0 | 29,057 | 219,625 |
| Accrued expenses | 2,025,173 | 2,406,731 | 2,153,906 | 2,540,493 |
| Operating lease liabilities | 178,217 | 164,461 | 155,926 | 143,327 |
| Total current liabilities | 2,798,264 | 3,631,498 | 2,580,360 | 3,185,982 |
| Contingent consideration | 2,946,743 | 2,939,316 | 2,883,423 | 4,604,456 |
| Deferred tax liability | 102,152 | 102,152 | 490,690 | 490,690 |
| Deferred collaboration revenue | 1,250,000 | 1,250,000 | 1,250,000 | 1,250,000 |
| Non-current operating lease liabilities | 195,369 | 203,798 | 248,239 | 287,079 |
| Total non-current liabilities | 4,494,264 | 4,495,266 | 4,872,352 | 6,632,225 |
| Total liabilities | 7,292,528 | 8,126,764 | 7,452,712 | 9,818,207 |
| Preferred stock, 0.01 par value 10,000,000 shares authorized 3,750 designated series a, 0 shares issued and outstanding 10,000 designated series b, 0 shares issued and outstanding 10,000 shares designated series c, 0 shares issued and outstanding 20,000 shares designated series d, 7 shares issued and outstanding 1,280 shares designated series e, 0 shares issued and outstanding 3,908 shares designated series f, 420 issued and outstanding at march31, 2026 and december31, 2025, respectively | 4 | 4 | 4 | 4 |
| Common stock, 0.01 par value 150,000,000 shares authorized 3,993,469 and 3,761,739 shares issued and outstanding at march31, 2026 and december31, 2025, respectively | 277,606 | 275,289 | 272,006 | 272,006 |
| Additional paid-in capital | 170,521,007 | 170,314,656 | 170,083,195 | 169,828,797 |
| Accumulated deficit | -156,635,260 | -154,217,276 | -147,700,755 | -147,727,561 |
| Accumulated other comprehensive loss | -228,796 | -246,137 | -243,708 | -245,770 |
| Total stockholders equity | 13,934,561 | 16,126,536 | 22,410,742 | 22,127,476 |
| Total liabilities and stockholders equity | 21,227,089 | 24,253,300 | 29,863,454 | 31,945,683 |
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)